| 1 |
Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460:705-10.
|
| 2 |
Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158-66.
DOI
|
| 3 |
Kee HJ, Kim GR, Cho SN, et al. miR-18a-5p microRNA increases vascular smooth muscle cell differentiation by downregulating syndecan4. Korean Circ J 2014;44:255-63.
DOI
|
| 4 |
Cizmeci-Smith G, Langan E, Youkey J, Showalter LJ, Carey DJ. Syndecan-4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:172-80.
DOI
ScienceOn
|
| 5 |
Xie C, Zhang J, Chen YE. MicroRNA and vascular smooth muscle cells. Vitam Horm 2011;87:321-39.
DOI
|
| 6 |
Li P, Zhu N, Yi B, et al. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 2013;113:1117-27.
DOI
|
| 7 |
Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 2005;280:9719-27.
DOI
|
| 8 |
McDonald OG, Owens GK. Programming smooth muscle plasticity with chromatin dynamics. Circ Res 2007;100:1428-41.
DOI
|
| 9 |
Wang DZ, Olson EN. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr Opin Genet Dev 2004;14:558-66.
DOI
ScienceOn
|
| 10 |
Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-9.
DOI
|
| 11 |
Cao D, Wang Z, Zhang CL, et al. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol Cell Biol 2005;25:364-76.
DOI
|
| 12 |
McDonald OG, Wamhoff BR, Hoofnagle MH, Owens GK. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 2006;116:36-48.
|
| 13 |
Boehm M, Slack FJ. MicroRNA control of lifespan and metabolism. Cell Cycle 2006;5:837-40.
DOI
|
| 14 |
Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007;26:133-7.
DOI
ScienceOn
|
| 15 |
Zhao Y, Srivastava D. A developmental view of microRNA function. Trends Biochem Sci 2007;32:189-97.
DOI
|
| 16 |
Gurtan AM, Sharp PA. The role of miRNAs in regulating gene expression networks. J Mol Biol 2013;425:3582-600.
DOI
|
| 17 |
Albinsson S, Sward K. Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol Res 2013;75:28-36.
DOI
|
| 18 |
Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.
DOI
ScienceOn
|
webmaster
